DK2462098T3 - Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre - Google Patents

Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre

Info

Publication number
DK2462098T3
DK2462098T3 DK10742083.8T DK10742083T DK2462098T3 DK 2462098 T3 DK2462098 T3 DK 2462098T3 DK 10742083 T DK10742083 T DK 10742083T DK 2462098 T3 DK2462098 T3 DK 2462098T3
Authority
DK
Denmark
Prior art keywords
halobiphenyl
derivatives
procedure
preparation
cyclopropancarboxylic acid
Prior art date
Application number
DK10742083.8T
Other languages
English (en)
Inventor
Fausto Pivetti
Maria Gioia Fornaretto
Marco Re
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK2462098T3 publication Critical patent/DK2462098T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/14—Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/58—Platinum group metals with alkali- or alkaline earth metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10742083.8T 2009-08-04 2010-07-22 Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre DK2462098T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09167206 2009-08-04
PCT/EP2010/004481 WO2011015287A2 (en) 2009-08-04 2010-07-22 Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

Publications (1)

Publication Number Publication Date
DK2462098T3 true DK2462098T3 (da) 2013-11-25

Family

ID=41479261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10742083.8T DK2462098T3 (da) 2009-08-04 2010-07-22 Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre

Country Status (21)

Country Link
US (1) US9056818B2 (da)
EP (1) EP2462098B1 (da)
JP (2) JP5996428B2 (da)
KR (1) KR101737653B1 (da)
CN (1) CN102596879B (da)
AU (1) AU2010281069B2 (da)
BR (1) BR112012002500A2 (da)
CA (1) CA2769960C (da)
DK (1) DK2462098T3 (da)
ES (1) ES2437163T3 (da)
HR (1) HRP20140032T1 (da)
IL (1) IL217886A (da)
MX (1) MX2012001411A (da)
MY (1) MY152980A (da)
PT (1) PT2462098E (da)
RU (1) RU2540076C2 (da)
SG (1) SG178239A1 (da)
SI (1) SI2462098T1 (da)
UA (1) UA106619C2 (da)
WO (1) WO2011015287A2 (da)
ZA (1) ZA201200821B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133322A1 (en) * 2008-06-11 2009-12-16 CHIESI FARMACEUTICI S.p.A. Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
JP5996428B2 (ja) * 2009-08-04 2016-09-21 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 1−(2−ハロビフェニル−4−イル)−シクロプロパンカルボン酸の誘導体の調製方法
CA2794940A1 (en) 2010-04-01 2011-10-06 Chiesi Farmaceutici S.P.A. Novel polymorphs and salts
US8975438B2 (en) * 2011-07-13 2015-03-10 Hoffmann-La Roche Inc. Process for the preparation of cyclohexanecarboxylic acid derivatives
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
AR090581A1 (es) 2012-04-04 2014-11-19 Chiesi Farma Spa Derivados de acidos 1-(2-halo-bifenil-4-il)-alcancarboxilicos para el tratamiento de enfermedades neurodegenerativas
CN105658615A (zh) * 2013-06-24 2016-06-08 奇斯药制品公司 用于制备1-(2-氟[1,1′-联苯]-4-基)-环丙烷甲酸衍生物的改进方法
EP2818460A1 (en) * 2013-06-24 2014-12-31 ZaCh System S.p.A. Cyclopropanation of substituted phenylacetonitriles or phenyl acetates
CA3230151A1 (en) 2021-08-31 2023-03-09 Cerespir Incorporated Co-crystals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101088272B1 (ko) * 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물
ITMI20030311A1 (it) * 2003-02-21 2004-08-22 Chiesi Farma Spa Acidi 2-fenil-2-dialchil-acetici per il trattamento della malattia di alzheimer.
JP2005047842A (ja) * 2003-07-31 2005-02-24 Mitsubishi Chemicals Corp 有機化合物の製造方法
EP1650183A1 (en) * 2004-10-21 2006-04-26 Cellzome Ag (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
AU2006257670A1 (en) * 2005-06-14 2006-12-21 Merck Frosst Canada Ltd Reversible inhibitors of monoamine oxidase A and B
CN101583598B (zh) * 2007-01-15 2012-09-12 参天制药株式会社 具有IκB激酶β抑制活性的新型吲哚衍生物
EP2133322A1 (en) * 2008-06-11 2009-12-16 CHIESI FARMACEUTICI S.p.A. Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
JP5996428B2 (ja) * 2009-08-04 2016-09-21 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 1−(2−ハロビフェニル−4−イル)−シクロプロパンカルボン酸の誘導体の調製方法

Also Published As

Publication number Publication date
CN102596879B (zh) 2015-01-28
RU2012104795A (ru) 2013-09-10
MY152980A (en) 2014-12-15
HK1168588A1 (en) 2013-01-04
JP5996428B2 (ja) 2016-09-21
CA2769960A1 (en) 2011-02-10
UA106619C2 (uk) 2014-09-25
ES2437163T3 (es) 2014-01-09
JP6001112B2 (ja) 2016-10-05
SG178239A1 (en) 2012-03-29
WO2011015287A3 (en) 2011-03-31
US20110039934A1 (en) 2011-02-17
BR112012002500A2 (pt) 2018-03-13
ZA201200821B (en) 2013-05-29
WO2011015287A2 (en) 2011-02-10
IL217886A (en) 2014-11-30
EP2462098A2 (en) 2012-06-13
RU2540076C2 (ru) 2015-01-27
AU2010281069A1 (en) 2012-02-23
KR101737653B1 (ko) 2017-05-18
AU2010281069B2 (en) 2015-09-10
CA2769960C (en) 2017-04-18
PT2462098E (pt) 2013-12-04
US9056818B2 (en) 2015-06-16
SI2462098T1 (sl) 2014-01-31
JP2015131824A (ja) 2015-07-23
MX2012001411A (es) 2012-03-29
KR20120050977A (ko) 2012-05-21
JP2013501010A (ja) 2013-01-10
CN102596879A (zh) 2012-07-18
EP2462098B1 (en) 2013-10-23
IL217886A0 (en) 2012-03-29
HRP20140032T1 (hr) 2014-02-14

Similar Documents

Publication Publication Date Title
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
DK2247577T4 (da) Fremgangsmåde til regioselektiv syntese af 1-alkyl-3-haloalkyl-pyrazol-4-carboxylsyrederivater
DK2513063T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-/1-aryl-5-pyrazolcarboxylsyrederivater
DK3354657T3 (da) Fremgangsmåde til fremstilling af planteafledte proteiner
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2310437T3 (da) Fremgangsmåde til kontinuerlig fremstilling af polyestere
DK2853265T3 (da) Fremgangsmåder til at øge stabiliseringen af hypoxi-inducerbar faktor-1-alpha
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
DK2220021T3 (da) Fremgangsmåde til fremstilling af terephtalsyre
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2558199T3 (da) Fremgangsmåde til fremstilling af bårne ædelmetalkatalysatorer via hydrothermal deponering
DK3192500T3 (da) Sammensætninger til kontinuerlig indgivelse af dopa-decarboxylasehæmmere
DK2114853T3 (da) Fremgangsmåde til fremstilling af glycerolestere
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
HUE052219T2 (hu) Eljárás kinolon vegyületek elõállítására
SI2358641T1 (sl) Postopek priprave titanatov
DK2462108T3 (da) Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider
BR112012014449A2 (pt) composições biocidas que compreendem derivados do ácido piroglutâmico
BR112012002500A2 (pt) Processo para o preparo de derivados de ácido 1- (2-halobifenil-4-yl) - ciclopropanocarboxílico
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2456760T3 (da) Fremgangsmåde til fremstilling af arylsubstituerede pyrazoler
DK2493860T3 (da) Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater
DK2310012T3 (da) Fremgangsmåde til fremstilling af substituerede pyrimidinderivater